Chemistry Core
Chemistry Core
批准号:
8139981
负责人:
CRAIG LINDSLEY
金额:
$331.86万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-06-01 至 2014-05-31
中文摘要
化学核心
化学核心是这项提议的中心组成部分,将负责参与
通过专业筛选和综合中心加快探头开发计划,雇用
探针开发中的TES和药物化学设计原则,整合化学信息学和
计算化学融入高温超导分流和探针设计,执行大规模的探针合成
分子,开发先进的分子工具,提供TES,并行合成和
跨MLPCN的药物化学。化学核心将与信息学和
管理核心,以确保实现MLPCN目标。以下具体目标概括了主要内容
化学核心的功能:
目的1.利用TES和药物化学快速开发高质量的探针分子
来自计算化学工具的输入和分析的设计原则,以及
每季度向MLSMR提交所有合成的化合物。
目标2.使用我们内部的ADME/DMPK组件以及In Silico方法来进一步
优化高质量的MLPCN探针分子。
目的3.大规模合成范德比尔特开发的探针分子(>;5g)
并跨越MLPCN,优化化合物配方。
目标4.与信息学核心合作处理化合物的重叠责任
登记和复合管理。
目标5.对MLPCN的化学家进行TES和并行合成技术方面的培训,以加快
其他化学和综合中心的探索发展。
英文摘要
CHEMISTRY CORE
The Chemistry Core is the central component of this proposal and will be responsible for engaging in
accelerated probe development programs with Specialty Screening and Comprehensive Centers, employing
TES and medicinal chemistry design principles in probe development, integrating cheminformatics and
computational chemistry into HTS triage and probe design, executing large scale synthesis of probe
molecules, developing advanced molecular tools and providing training for TES, parallel synthesis and
medicinal chemistry across the MLPCN. The Chemistry Core will work closely with Informatics and
Administrative Core to ensure MLPCN goals are met. The following specific aims summarize the major
functions of the chemistry core:
AIM 1. To rapidly develop high quality probe molecules employing TES and medicinal chemistry
design principles with input from, and analysis with, computational chemistry tools, and to
submit all compounds synthesized to the MLSMR on a quarterly basis.
AIM 2. To employ our internal ADME/DMPK component along with in silico methods to further
optimize high quality MLPCN probe molecules .
AIM 3. To perform large scale synthesis (>5 g) of probe molecules developed both at Vanderbilt
and across the MLPCN and optimize compound formulation.
AIM 4. To collaborate with the Informatics Core for the overlapping responsibility of compound
registration and compound management.
AIM 5. To train chemists across the MLPCN in the art of TES and parallel synthesis to accelerate
probe development at other Chemistry and Comprehensive Centers.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of mGlu7 receptor allosteric modulators for neurological and psychiatric disorders
-
批准号:10426338
-
项目类别:
-
资助金额:$69.49万
-
财政年份:2020
-
负责人:CRAIG LINDSLEY
-
依托单位:
Development of mGlu7 receptor allosteric modulators for neurological and psychiatric disorders
-
批准号:10674501
-
项目类别:
-
资助金额:$69.77万
-
财政年份:2020
-
负责人:CRAIG LINDSLEY
-
依托单位:
Development of mGlu7 receptor allosteric modulators for neurological and psychiatric disorders
-
批准号:10093390
-
项目类别:
-
资助金额:$74.11万
-
财政年份:2020
-
负责人:CRAIG LINDSLEY
-
依托单位:
Development of mGlu7 receptor allosteric modulators for neurological and psychiatric disorders
-
批准号:10266776
-
项目类别:
-
资助金额:$69.51万
-
财政年份:2020
-
负责人:CRAIG LINDSLEY
-
依托单位:
Allosteric modulators of the glucagon-like peptide-1 receptor
-
批准号:8996184
-
项目类别:
-
资助金额:$16.87万
-
财政年份:2014
-
负责人:CRAIG LINDSLEY
-
依托单位:
Center base project #2
-
批准号:8189624
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2010
-
负责人:CRAIG LINDSLEY
-
依托单位:
Medicinal Chemistry
-
批准号:7988517
-
项目类别:
-
资助金额:$63.5万
-
财政年份:2010
-
负责人:CRAIG LINDSLEY
-
依托单位:
Center base project #1
-
批准号:8189623
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2010
-
负责人:CRAIG LINDSLEY
-
依托单位:
Administrative Core
-
批准号:8139980
-
项目类别:
-
资助金额:$26.82万
-
财政年份:2010
-
负责人:CRAIG LINDSLEY
-
依托单位:
Partial Antagonists of mGluR5 for Treatment of Cocaine Addiction
-
批准号:7347914
-
项目类别:
-
资助金额:$42.83万
-
财政年份:2008
-
负责人:CRAIG LINDSLEY
-
依托单位:
The Vanderbilt Specialized Chemistry Center for Accelerated Probe Development
-
批准号:8139983
-
项目类别:
-
资助金额:$518.84万
-
财政年份:2008
-
负责人:CRAIG LINDSLEY
-
依托单位:
Selective M1 mAChR allosteric modulators for the treatment of schizophrenia
-
批准号:8706961
-
项目类别:
-
资助金额:$39.23万
-
财政年份:2008
-
负责人:CRAIG LINDSLEY
-
依托单位:
Selective M1 mAChR allosteric modulators for the treatment of schizophrenia
-
批准号:9250204
-
项目类别:
-
资助金额:$39.25万
-
财政年份:2008
-
负责人:CRAIG LINDSLEY
-
依托单位:
Selective M1 mAChR allosteric modulators for the treatment of schizophrenia
-
批准号:7625071
-
项目类别:
-
资助金额:$34.54万
-
财政年份:2008
-
负责人:CRAIG LINDSLEY
-
依托单位:
Partial Antagonists of mGluR5 for Treatment of Cocaine Addiction
-
批准号:8071079
-
项目类别:
-
资助金额:$39.86万
-
财政年份:2008
-
负责人:CRAIG LINDSLEY
-
依托单位:
Selective M1 mAChR allosteric modulators for the treatment of schizophrenia
-
批准号:8260205
-
项目类别:
-
资助金额:$34.19万
-
财政年份:2008
-
负责人:CRAIG LINDSLEY
-
依托单位:
Partial Antagonists of mGluR5 for Treatment of Cocaine Addiction
-
批准号:8262403
-
项目类别:
-
资助金额:$39.44万
-
财政年份:2008
-
负责人:CRAIG LINDSLEY
-
依托单位:
Selective M1 mAChR allosteric modulators for the treatment of schizophrenia
-
批准号:8503224
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2008
-
负责人:CRAIG LINDSLEY
-
依托单位:
Partial Antagonists of mGluR5 for Treatment of Cocaine Addiction
-
批准号:7629161
-
项目类别:
-
资助金额:$42.5万
-
财政年份:2008
-
负责人:CRAIG LINDSLEY
-
依托单位:
Selective M1 mAChR allosteric modulators for the treatment of schizophrenia
-
批准号:8068235
-
项目类别:
-
资助金额:$34.19万
-
财政年份:2008
-
负责人:CRAIG LINDSLEY
-
依托单位:
国内基金
海外基金
SCIENCE CHINA Chemistry
-
批准号:21224001
-
项目类别:专项基金项目
-
资助金额:24.0万元
-
批准年份:2012
-
负责人:朱晓文
-
依托单位:
Science China Chemistry
-
批准号:21024801
-
项目类别:专项基金项目
-
资助金额:24.0万元
-
批准年份:2010
-
负责人:朱晓文
-
依托单位:
运用Linkage Chemistry合成新型聚合物缀合物和刷形共聚物
-
批准号:20974058
-
项目类别:面上项目
-
资助金额:12.0万元
-
批准年份:2009
-
负责人:袁金颖
-
依托单位: